Skip to main content

Advertisement

Log in

SERPINE-1 Gene Methylation and Protein as Molecular Predictors of Laparoscopic Sleeve Gastrectomy Outcome

  • Original Contributions
  • Published:
Obesity Surgery Aims and scope Submit manuscript

Abstract

Background

Body weight is subjected to genetic and epigenetic modifiers that might affect the success of weight loss interventions. Because of its possible complications and disparity in patients’ response, identification of predictors to the outcome of bariatric surgery is indispensable.

Objectives

This prospective study aims to investigate serpin peptidase inhibitor type 1 (SERPINE-1) protein and gene methylation as molecular predictors to the outcome of bariatric surgery.

Patients and Methods

One hundred participants were enrolled and divided to control group (n = 50) and obese patients who underwent laparoscopic sleeve gastrectomy (LSG) (n = 50). Anthropometric measurements were assessed and blood samples were collected preoperatively and 6 months postoperatively for assessment of SERPINE-1 protein and gene methylation, C-reactive protein (CRP), and homeostatic model assessment of insulin resistance (HOMA-IR). Moreover, subjects were followed for 2 years for weight loss parameters.

Results

Patients with obesity showed high baseline SERPINE-1 protein and gene hypermethylation where LSG was followed by a drop in SERPINE-1 protein level but not gene hypermethylation. Baseline SERPINE-1 gene methylation was negatively related to postoperative weight loss and was the independent predictor to weight loss after LSG. Likewise, postoperative SERPINE-1 protein was negatively related to weight loss with independent expression from its gene methylation state. Furthermore, postoperative SERPINE-1 gene methylation correlated to CRP and HOMA-IR.

Conclusion

Baseline SERPINE-1 gene methylation might be a predictor of weight loss after LSG. Meanwhile, postoperative SERPINE-1 protein could be a predictor to weight loss maintenance after LSG. Lastly, postoperative SERPINE-1 gene methylation might serve as an index to postoperative changes in obesity-related comorbidities.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Uzogara SG. Obesity epidemic, medical and quality of life consequences: a review. International Journal of Public Health Research. 2017;5(1):1.

    Google Scholar 

  2. El Bcheraoui C, Afshin A, Charara R, et al. Burden of obesity in the Eastern Mediterranean region: findings from the Global Burden of Disease 2015 study. International Journal of Public Health. 2018;63(1):165–76. https://doi.org/10.1007/s00038-017-1002-5.

    Article  Google Scholar 

  3. Shoelson SE, Herrero L, Naaz A. Obesity, inflammation, and insulin resistance. Gastroenterology. 2007;132(6):2169–80.

    CAS  PubMed  Google Scholar 

  4. Schenk S, Saberi M, Olefsky JM. Insulin sensitivity: modulation by nutrients and inflammation. J Clin Invest. 2008;118(9):2992–3002.

    CAS  PubMed  PubMed Central  Google Scholar 

  5. Hagman DK, Larson I, Kuzma JN, et al. The short-term and long- term effects of bariatric/metabolic surgery on subcutaneous adipose tissue inflammation in humans. Metabolism. 2017;70:12–22.

    CAS  PubMed  PubMed Central  Google Scholar 

  6. Colquitt JL, Pickett K, Loveman E, et al. Surgery for weight loss in adults. Cochrane Database Syst Rev. 2014;8

  7. Buchwald H, Oien DM. Metabolic/bariatric surgery worldwide 2011. Obes Surg. 2013;23(4):427–36.

    PubMed  Google Scholar 

  8. Peterli R, Steinert RE, Woelnerhanssen B, et al. Metabolic and hormonal changes after laparoscopic Roux-en-Y gastric bypass and sleeve gastrectomy: a randomized, prospective trial. Obes Surg. 2012;22(5):740–8.

    PubMed  PubMed Central  Google Scholar 

  9. Saleh M, Cheruvu MS, Moorthy K, et al. Laparoscopic sleeve gastrectomy using a synthetic bioabsorbable staple line reinforcement material: post-operative complications and 6 year outcomes. Annals of Medicine and Surgery. 2016;10:83–7.

    PubMed  PubMed Central  Google Scholar 

  10. Baltasar A, Serra C, Pérez N, et al. Laparoscopic sleeve gastrectomy: a multi-purpose bariatric operation. Obes Surg. 2005;15(8):1124–8.

    PubMed  Google Scholar 

  11. Roa PE, Kaidar-Person O, Pinto D, et al. Laparoscopic sleeve gastrectomy as treatment for morbid obesity: technique and short-term outcome. Obes Surg. 2006;16(10):1323–6.

    PubMed  Google Scholar 

  12. Salem L, Jensen CC, Flum DR. Are bariatric surgical outcomes worth their cost? A systematic review. J Am Coll Surg. 2005;200(2):270–8.

    PubMed  Google Scholar 

  13. Sillén L, Andersson E. Patient factors predicting weight loss after Roux-en-Y gastric bypass. J Obes. 2017;2017

  14. Feinbloom D, Bauer KA. Assessment of hemostatic risk factors in predicting arterial thrombotic events. Arterioscler Thromb Vasc Biol. 2005;25(10):2043–53.

    CAS  PubMed  Google Scholar 

  15. Placencio VR, DeClerck YA. Plasminogen activator inhibitor-1 in cancer: rationale and insight for future therapeutic testing. Cancer Res. 2015;75(15):2969–74.

    CAS  PubMed  PubMed Central  Google Scholar 

  16. Cesari M, Pahor M, Incalzi RA. Plasminogen activator inhibitor-1 (PAI-1): a key factor linking fibrinolysis and age-related subclinical and clinical conditions. Cardiovasc Ther. 2010;28(5):e72–91.

    CAS  PubMed  Google Scholar 

  17. Orenes-Piñero E, Pineda J, Roldán V, et al. Effects of body mass index on the lipid profile and biomarkers of inflammation and a fibrinolytic and prothrombotic state. J Atheroscler Thromb. 2015;26161

  18. Ohkura N, Oishi K, Atsumi G-i. Blood coagulation and metabolic profiles in middle-aged male and female ob/ob mice. Blood Coagul Fibrinolysis. 2015;26(5):522–6.

    CAS  PubMed  Google Scholar 

  19. Chen R, Yan J, Liu P, et al. Plasminogen activator inhibitor links obesity and thrombotic cerebrovascular diseases: the roles of PAI-1 and obesity on stroke. Metab Brain Dis. 2017;32(3):667–73.

    CAS  PubMed  Google Scholar 

  20. Duggan C, de Dieu TJ, Wang C-Y, et al. Dietary weight loss and exercise effects on serum biomarkers of angiogenesis in overweight postmenopausal women: a randomized controlled trial. Cancer Res. 2016;76(14):4226–35.

    CAS  PubMed  PubMed Central  Google Scholar 

  21. Mossberg KE, Pournaras DJ, Welbourn R, et al. Differential response of plasma plasminogen activator inhibitor 1 after weight loss surgery in patients with or without type 2 diabetes. Surg Obes Relat Dis. 2017;13(1):53–7.

    PubMed  Google Scholar 

  22. Aronica L, Levine AJ, Brennan K, et al. A systematic review of studies of DNA methylation in the context of a weight loss intervention. Epigenomics. 2017;9(5):769–87.

    CAS  PubMed  Google Scholar 

  23. Sala P, de Miranda Torrinhas RSM, Fonseca DC, et al. Tissue-specific methylation profile in obese patients with type 2 diabetes before and after Roux-en-Y gastric bypass. Diabetol Metab Syndr. 2017;9(1):15.

    PubMed  PubMed Central  Google Scholar 

  24. Moleres A, Campión J, Milagro FI, et al. Differential DNA methylation patterns between high and low responders to a weight loss intervention in overweight or obese adolescents: the EVASYON study. FASEB J. 2013;27(6):2504–12.

    CAS  PubMed  Google Scholar 

  25. Bouchard L, Rabasa-Lhoret R, Faraj M, et al. Differential epigenomic and transcriptomic responses in subcutaneous adipose tissue between low and high responders to caloric restriction. Am J Clin Nutr. 2009;91(2):309–20.

    PubMed  Google Scholar 

  26. Zhao J, Goldberg J, Vaccarino V. Promoter methylation of serotonin transporter gene is associated with obesity measures: a monozygotic twin study. Int J Obes. 2013;37(1):140.

    CAS  Google Scholar 

  27. Barres R, Kirchner H, Rasmussen M, et al. Weight loss after gastric bypass surgery in human obesity remodels promoter methylation. Cell Rep. 2013;3(4):1020–7.

    CAS  PubMed  Google Scholar 

  28. Kirchner H, Nylen C, Laber S, et al. Altered promoter methylation of PDK4, IL1 B, IL6, and TNF after Roux-en Y gastric bypass. Surg Obes Relat Dis. 2014;10(4):671–8.

    PubMed  Google Scholar 

  29. Lopez-Legarrea P, Mansego ML, Zulet MA, et al. SERPINE1, PAI-1 protein coding gene, methylation levels and epigenetic relationships with adiposity changes in obese subjects with metabolic syndrome features under dietary restriction. J Clin Biochem Nutr. 2013;53(3):139–44.

    CAS  PubMed  PubMed Central  Google Scholar 

  30. Mechanick JI, Youdim A, Jones DB, et al. Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient—2013 update: cosponsored by American Association of Clinical Endocrinologists, the Obesity Society, and American Society for Metabolic & Bariatric Surgery. Obesity. 2013;21(S1):S1–S27.

    CAS  PubMed  Google Scholar 

  31. Janssen I, Katzmarzyk PT, Ross R. Waist circumference and not body mass index explains obesity- related health risk. Am J Clin Nutr. 2004;79(3):379–84.

    CAS  PubMed  Google Scholar 

  32. Ikeda Y, SUEHIRO T, Nakamura T, et al. Clinical significance of the insulin resistance index as assessed by homeostasis model assessment. Endocr J. 2001;48(1):81–6.

    PubMed  Google Scholar 

  33. Nicoletti CF, Nonino CB, de Oliveira BAP, et al. DNA methylation and hydroxymethylation levels in relation to two weight loss strategies: energy - restricted diet or bariatric surgery. Obes Surg. 2016;26(3):603–11.

    PubMed  Google Scholar 

  34. Che Y, Wang J, Li Y, et al. Cisplatin-activated PAI-1 secretion in the cancer- associated fibroblasts with paracrine effects promoting esophageal squamous cell carcinoma progression and causing chemoresistance. Cell Death Dis. 2018;9(7):759. https://doi.org/10.1038/s41419-018-0808-2.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Lo PK WH, Cheng PC, Teo WW, Liang X, Argani P, Lee JS, Sukumar S. MethySYBR, a novel quantitative PCR assay for the dual analysis of DNA methylation and CpG methylation density. J Mol Diagn. 2009;1(11(5)):400–14.

  36. Bonouvrie DS, Uittenbogaart M, Luijten A, et al. Lack of standard definitions of primary and secondary (non)responders after primary gastric bypass and gastric sleeve: a systematic review. Obes Surg. 2019;29(2):691–7. https://doi.org/10.1007/s11695-018-3610-4.

    Article  PubMed  Google Scholar 

  37. Coppede F, Seghieri M, Stoccoro A, et al. DNA methylation of genes regulating appetite and prediction of weight loss after bariatric surgery in obese individuals. J Endocrinol Investig. 2019;42(1):37–44. https://doi.org/10.1007/s40618-018-0881-5.

    Article  CAS  Google Scholar 

  38. Saltiel AR, Olefsky JM. Inflammatory mechanisms linking obesity and metabolic disease. J Clin Invest. 2017;127(1):1–4.

    PubMed  PubMed Central  Google Scholar 

  39. Laddu D, Hauser M. Addressing the nutritional phenotype through personalized nutrition for chronic disease prevention and management. Prog Cardiovasc Dis. 2018;

  40. Butler AA, O’Rourke RW. Bariatric surgery in the era of personalized medicine. Gastroenterol Ogy. 2013;144(3):497–500. https://doi.org/10.1053/j.gastro.2013.01.027.

    Article  Google Scholar 

  41. Izquierdo AG, Crujeiras AB. Obesity-related epigenetic changes after bariatric surgery. Front Endocrinol (Lausanne). 2019;10:232. https://doi.org/10.3389/fendo.2019.00232.

    Article  Google Scholar 

  42. Hermsdorff HHM, Zulet MA, Abete I, et al. A legume-based hypocaloric diet reduces proinflammatory status and improves metabolic features in overweight/obese subjects. Eur J Nutr. 2011;50(1):61–9.

    CAS  PubMed  Google Scholar 

  43. Paepegaey A-C, Genser L, Bouillot J-L, et al. High levels of CRP in morbid obesity: the central role of adipose tissue and lessons for clinical practice before and after bariatric surgery. Surg Obes Relat Dis. 2015;11(1):148–54.

    PubMed  Google Scholar 

  44. Pardina E, Ferrer R, Baena-Fustegueras JA, et al. Only C-reactive protein, but not TNF-α or IL6, reflects the improvement in inflammation after bariatric surgery. Obes Surg. 2012;22(1):131–9.

    PubMed  Google Scholar 

  45. Haluzikova D, Lacinova Z, Kavalkova P, et al. Laparoscopic sleeve gastrectomy differentially affects serum concentrations of FGF-19 and FGF-21 in morbidly obese subjects. Obesity. 2013;21(7):1335–42.

    CAS  PubMed  Google Scholar 

  46. Ruiz-Tovar J, Oller I, Galindo I, et al. Change in levels of C-reactive protein (CRP) and serum cortisol in morbidly obese patients after laparoscopic sleeve gastrectomy. Obes Surg. 2013;23(6):764–9.

    PubMed  Google Scholar 

  47. Iannelli A, Anty R, Schneck AS, et al. Inflammation, insulin resistance, lipid disturbances, anthropometrics, and metabolic syndrome in morbidly obese patients: a case control study comparing laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy. Surgery. 2011;149(3):364–70. https://doi.org/10.1016/j.surg.2010.08.013.

    Article  PubMed  Google Scholar 

  48. Woelnerhanssen B, Peterli R, Steinert RE, et al. Effects of postbariatric surgery weight loss on adipokines and metabolic parameters: comparison of laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy--a prospective randomized trial. Surgery for Obesity and Related Diseases: official journal of the American Society for Bariatric Surgery. 2011;7(5):561–8. https://doi.org/10.1016/j.soard.2011.01.044.

    Article  Google Scholar 

  49. Rao RS, Yanagisawa R, Kini S. Insulin resistance and bariatric surgery. Obesity Reviews: an official journal of the International Association for the Study of Obesity. 2012;13(4):316–28. https://doi.org/10.1111/j.1467-789X.2011.00955.x.

    Article  CAS  Google Scholar 

  50. Tschoner A, Sturm W, Engl J, et al. Plasminogen activator inhibitor 1 and visceral obesity during pronounced weight loss after bariatric surgery. Nutr Metab Cardiovasc Dis. 2012;22(4):340–6.

    CAS  PubMed  Google Scholar 

  51. Carraro JC, Mansego ML, Milagro FI, et al. LINE-1 and inflammatory gene methylation levels are early biomarkers of metabolic changes: association with adiposity. Biomarkers: biochemical indicators of exposure, response, and susceptibility to chemicals. 2016;21(7):625–32. https://doi.org/10.3109/1354750x.2016.1171904.

    Article  CAS  Google Scholar 

  52. Martín-Núñez G, Cabrera-Mulero A, Alcaide-Torres J, et al. No effect of different bariatric surgery procedures on LINE-1 DNA methylation in diabetic and nondiabetic morbidly obese patients. Surg Obes Relat Dis. 2017;13(3):442–50.

    PubMed  Google Scholar 

  53. Talens RP, Boomsma DI, Tobi EW, et al. Variation, patterns, and temporal stability of DNA methylation: considerations for epigenetic epidemiology. FASEB J. 2010;24(9):3135–44.

    CAS  PubMed  Google Scholar 

  54. Pucci A, Batterham RL. Mechanisms underlying the weight loss effects of RYGB and SG: similar, yet different. J Endocrinol Investig. 2019;42(2):117–28. https://doi.org/10.1007/s40618-018-0892-2.

    Article  CAS  Google Scholar 

  55. Cordero P, Campion J, Milagro FI, et al. Leptin and TNF-alpha promoter methylation levels measured by MSP could predict the response to a low-calorie diet. J Physiol Biochem. 2011;67(3):463–70.

    CAS  PubMed  Google Scholar 

  56. Crujeiras AB, Campion J, Díaz-Lagares A, et al. Association of weight regain with specific methylation levels in the NPY and POMC promoters in leukocytes of obese men: a translational study. Regul Pept. 2013;186:1–6.

    CAS  PubMed  Google Scholar 

  57. Gelaye B, Revilla L, Lopez T, et al. Association between insulin resistance and c-reactive protein among Peruvian adults. Diabetol Metab Syndr. 2010;2(1):30. https://doi.org/10.1186/1758-5996-2-30.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  58. Laaksonen D, Niskanen L, Nyyssönen K, et al. C- reactive protein and the development of the metabolic syndrome and diabetes in middle-aged men. Diabetologia. 2004;47(8):1403–10.

    CAS  PubMed  Google Scholar 

  59. Yang JS, Gerber JN, You HJ. Association between fasting insulin and high-sensitivity C reactive protein in Korean adults. BMJ Open Sport Exerc Med. 2017;3(1):e000236. https://doi.org/10.1136/bmjsem-2017-000236.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

All authors declare that they have substantially contributed to the manuscript and have met the main criteria of authorship: conceptualization, methodology, data collecting and processing, writing and editing, and supervision.

Corresponding author

Correspondence to Doaa A. Abdelmonsif.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflict of interest.

Human and Animal Rights

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

Informed Consent

Informed consent was obtained from all individual participants included in the study.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic Supplementary Material

ESM 1

(DOCX 36 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Assem, S., Abdelbaki, T.N., Mohy-El Dine, S.H. et al. SERPINE-1 Gene Methylation and Protein as Molecular Predictors of Laparoscopic Sleeve Gastrectomy Outcome. OBES SURG 30, 2620–2630 (2020). https://doi.org/10.1007/s11695-020-04533-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11695-020-04533-0

Keywords

Navigation